Atai Life Stock Today


USD 3.22  0.11  3.30%   

Market Performance
0 of 100
Odds Of Distress
Over 52
Atai Life is trading at 3.22 as of the 24th of September 2022. This is a -3.3 percent decrease since the beginning of the trading day. The stock's open price was 3.33. Atai Life has 52 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Atai Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of September 2021 and ending today, the 24th of September 2022. Click here to learn more.
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 160.3 M outstanding shares of which 5.14 M shares are presently shorted by private and institutional investors with about 6.86 trading days to cover. More on Atai Life Sciences

Moving together with Atai Life

+0.64DISWalt Disney Fiscal Year End 9th of November 2022 PairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Atai Life Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Atai Life's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Atai Life or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Atai Life Sciences generated a negative expected return over the last 90 days
Atai Life Sciences has high historical volatility and very poor performance
Atai Life Sciences has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 496 K. Net Loss for the year was (205.36 M) with profit before overhead, payroll, taxes, and interest of 20.38 M.
Atai Life Sciences currently holds about 334.91 M in cash with (70.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.08.
Latest headline from Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics - PR Newswire UK
CEO, DirectorChengYaw Sun
Average Analyst Recommendation
Analysts covering Atai Life report their recommendations after researching Atai Life's financial statements, talking to executives and customers, or listening in on Atai Life's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Atai Life Sciences. The Atai Life consensus assessment is calculated by taking the average forecast from all of the analysts covering Atai Life.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Atai Life's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldUndervalued
Atai Life Sciences (ATAI) is traded on NASDAQ Exchange in USA and employs 87 people. The company currently falls under 'Small-Cap' category with current market capitalization of 637.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Atai Life's market, we take the total number of its shares issued and multiply it by Atai Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Atai Life Sciences conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 160.3 M outstanding shares of which 5.14 M shares are presently shorted by private and institutional investors with about 6.86 trading days to cover. Atai Life Sciences currently holds about 334.91 M in cash with (70.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.08.
Check Atai Life Probability Of Bankruptcy
Atai Life holds a total of one hundred sixty million three hundred thousand outstanding shares. Atai Life Sciences shows 9.41 percent if its outstanding shares held by insiders and 9.41 percent owned by other corporate entities . Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Atai Life Ownership Details

Atai Life Stock Price Odds Analysis

In reference to a normal probability distribution, the odds of Atai Life jumping above the current price in 90 days from now is about 99.0%. The Atai Life Sciences probability density function shows the probability of Atai Life stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.7761. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Atai Life will likely underperform. Additionally, the company has an alpha of 0.0308, implying that it can generate a 0.0308 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 3.22HorizonTargetOdds Above 3.22
1.04%90 days
Based on a normal probability distribution, the odds of Atai Life to move above the current price in 90 days from now is about 99.0 (This Atai Life Sciences probability density function shows the probability of Atai Life Stock to fall within a particular range of prices over 90 days) .

Atai Life Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Atai Life that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Atai Life's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Atai Life's value.
InstituionSecurity TypeTotal SharesValue
Morgan StanleyCommon Shares2.2 M7.8 M
Alpha Wave Global LpCommon Shares2.1 M7.8 M
View Atai Life Diagnostics

Atai Life Sciences Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Atai Life market risk premium is the additional return an investor will receive from holding Atai Life long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Atai Life. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Atai Life's alpha and beta are two of the key measurements used to evaluate Atai Life's performance over the market, the standard measures of volatility play an important role as well.

Atai Life Stock Against Markets

Picking the right benchmark for Atai Life stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Atai Life stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Atai Life is critical whether you are bullish or bearish towards Atai Life Sciences at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Atai Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Global Correlations Now


Global Correlations

Find global opportunities by holding instruments from different markets
All  Next Launch Module

Atai Life Corporate Directors

Atai Life corporate directors refer to members of an Atai Life board of directors. The board of directors generally takes responsibility for the Atai Life's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Atai Life's board members must vote for the resolution. The Atai Life board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Yiu Tsui - Independent DirectorProfile
Andrew Yan - Independent DirectorProfile
Lin Wang - Co-Founder, Consultant and DirectorProfile
Hope Ni - Independent DirectorProfile

Invested in Atai Life Sciences?

The danger of trading Atai Life Sciences is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Atai Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Atai Life. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Atai Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Atai Life Sciences information on this page should be used as a complementary analysis to other Atai Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Atai Life Stock analysis

When running Atai Life Sciences price analysis, check to measure Atai Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atai Life is operating at the current time. Most of Atai Life's value examination focuses on studying past and present price action to predict the probability of Atai Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atai Life's price. Additionally, you may evaluate how the addition of Atai Life to your portfolios can decrease your overall portfolio volatility.
Bond Directory
Find actively traded corporate debentures issued by US companies
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Global Correlations
Find global opportunities by holding instruments from different markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Atai Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atai Life. If investors know Atai Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atai Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Atai Life Sciences is measured differently than its book value, which is the value of Atai Life that is recorded on the company's balance sheet. Investors also form their own opinion of Atai Life's value that differs from its market value or its book value, called intrinsic value, which is Atai Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atai Life's market value can be influenced by many factors that don't directly affect Atai Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atai Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Atai Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atai Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.